The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1238
July 3, 2006
View Complete Issue         Table of Contents 2019 
Aspirin for Primary Prevention of Cardiovascular Disease (Revisited)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Aspirin for Primary Prevention of Cardiovascular Disease (Revisited)
July 3, 2006 (Issue: 1238)
When the use of aspirin for primary prevention of cardiovascular diseases was last reviewed in The Medical Letter, only one placebo-controlled prospective trial was available: the (male) Physicians' Health Study. Last year, a second large,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Aspirin for Primary Prevention of Cardiovascular Disease (Revisited)
Article code: 1238a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.